Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes

Hepatology

Volumn 58, Issue 1, 2013, Pages 31-42

  Meier, Anja ^a   Mehrle, Stefan ^a   Weiss, Thomas S ^b   Mier, Walter ^a   Urban, Stephan ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROLIPOAMIDE DEHYDROGENASE; F ACTIN;

ACTIN FILAMENT; ARTICLE; BINDING COMPETITION; CELL DIFFERENTIATION; COMPLEX FORMATION; CONTROLLED STUDY; ENDOCYTOSIS; HALF LIFE TIME; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID BILAYER; LIVER CELL; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; SPECIES DIFFERENCE; TURNOVER TIME;

ANIMALS; CELL DIFFERENTIATION; DOGS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HEP G2 CELLS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; KINETICS; MICE; MYRISTIC ACID; PROTEIN PRECURSORS; RABBITS; RATS; RECEPTORS, VIRUS; SPECIES SPECIFICITY; TUPAIA; VIRAL ENVELOPE PROTEINS;

EID: 84879604798     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26181     Document Type: Article

References (34)

1. Lok AS. Prevention of hepatitis B virus-related hepatocellular carcinoma. Gastroenterology 2004; 127( 5 Suppl 1): S303-S309.
2. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: summary of a clinical research workshop. HEPATOLOGY 2007; 45: 1056-1075.
3. Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004; 350: 1118-1129.
4. Bruss V. Hepatitis B virus morphogenesis. World J Gastroenterol 2007; 13: 65-73.
5. Lu X, Block TM, Gerlich WH. Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line. J Virol 1996; 70: 2277-2285.
6. Glebe D, Urban S. Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 2007; 13: 22-38.
7. Gripon P, Rumin S, Urban S, Le SJ, Glaise D, Cannie I, et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 2002; 99: 15655-15660.
8. Walter E, Keist R, Niederost B, Pult I, Blum HE. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. HEPATOLOGY 1996; 24: 1-5.
9. Leistner CM, Gruen-Bernhard S, Glebe D. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell Microbiol 2008; 10: 122-133.
10. Schulze A, Gripon P, Urban S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. HEPATOLOGY 2007; 46: 1759-1768.
11. Bruss V, Hagelstein J, Gerhardt E, Galle PR. Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity. Virology 1996; 218: 396-399.
12. Gripon P, Le SJ, Rumin S, Guguen-Guillouzo C. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 1995; 213: 292-299.
13. LeSeyec J, Chouteau P, Cannie I, Guguen-Guillouzo C, Gripon P. Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J Virol 1999; 73: 2052-2057.
14. Blanchet M, Sureau C. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J Virol 2007; 81: 5841-5849.
15. LeSeyec J, Chouteau P, Cannie I, Guguen-Guillouzo C, Gripon P. Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J Virol 1998; 72: 5573-5578.
16. Ni Y, Sonnabend J, Seitz S, Urban S. The pre-s2 domain of the hepatitis B virus is dispensable for infectivity but serves a spacer function for L-protein-connected virus assembly. J Virol 2010; 84: 3879-3888.
17. Abou-Jaoudé G, Sureau C. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange. J Virol 2007; 81: 13057-13066.
18. Schelhaas M, Malmstrom J, Pelkmans L, Haugstetter J, Ellgaard L, Grunewald K, et al. Simian Virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell 2007; 131: 516-529.
19. Glebe D, Aliakbari M, Krass P, Knoop EV, Valerius KP, Gerlich WH. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J Virol 2003; 77: 9511-9521.
20. Glebe D, Urban S, Knoop EV, Cag N, Krass P, Grun S, et al. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology 2005; 129: 234-245.
21. Schulze A, Schieck A, Ni Y, Mier W, Urban S. Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction. J Virol 2010; 84: 1989-2000.
22. Petersen J, Dandri M, Mier W, Lutgehetmann M, Volz T, von WF, et al. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol 2008; 26: 335-341.
23. Barrera A, Guerra B, Notvall L, Lanford RE. Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition. J Virol 2005; 79: 9786-9798.
24. Gripon P, Cannie I, Urban S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol 2005; 79: 1613-1622.
25. Schieck A, Schulze A, Gähler C, Müller T, Haberkorn U, Alexandrov A, et al. Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts. HEPATOLOGY 2013; 58: 43-53.
26. Weiss TS, Pahernik S, Scheruebl I, Jauch KW, Thasler WE. Cellular damage to human hepatocytes through repeated application of 5-aminolevulinic acid. J Hepatol 2003; 38: 476-482.
27. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976; 13: 29-83.
28. Gripon P, Diot C, Theze N, Fourel I, Loreal O, Brechot C, et al. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J Virol 1988; 62: 4136-4143.
29. Dandri M, Burda MR, Torok E, Pollok JM, Iwanska A, Sommer G, et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. HEPATOLOGY 2001; 33: 981-988.
30. Schulze A, Mills K, Weiss TS, Urban S. Hepatocyte polarization is essential for the productive entry of the hepatitis B virus. HEPATOLOGY 2012; 55: 373-383.
31. Gripon P, Diot C, Corlu A, Guguen-Guillouzo C. Regulation by dimethylsulfoxide, insulin, and corticosteroids of hepatitis B virus replication in a transfected human hepatoma cell line. J Med Virol 1989; 28: 193-199.
32. Gripon P, Diot C, Guguen-Guillouzo C. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration. Virology 1993; 192: 534-540.
33. Rumin S, Gripon P, Le SJ, Corral-Debrinski M, Guguen-Guillouzo C. Long-term productive episomal hepatitis B virus replication in primary cultures of adult human hepatocytes infected in vitro. J Viral Hepat 1996; 3: 227-238.
34. Ozer A, Khaoustov VI, Mearns M, Lewis DE, Genta RM, Darlington GJ, et al. Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication. Gastroenterology 1996; 110: 1519-1528.